Arcus Biosciences, Inc. (NASDAQ: RCUS) has recently caught the attention of investors, particularly due to the impressive potential upside of 231.16% as suggested by analyst target prices. This clinical-stage biopharmaceutical..
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is a compelling player in the biotechnology sector, standing out with a remarkable potential upside of 424.51%, capturing the attention of investors looking for high-reward..
AbCellera Biologics Inc. (NASDAQ: ABCL), a trailblazer in the biotechnology sector, is capturing attention with its impressive potential upside of 142.90%. Investors are keenly watching this Canadian-based company, which specializes..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a pioneering entity in the biotechnology sector, is capturing investor attention with its ambitious gene therapy pipeline. With a market capitalization of approximately $304.9 million,..
Zymeworks Inc. (NASDAQ: ZYME) is making waves in the biotechnology sector with its innovative approach to developing biotherapeutics targeting cancer and autoimmune diseases. As a clinical-stage company, Zymeworks is on..
Beta Bionics, Inc. (BBNX) stands at the forefront of healthcare innovation, specifically within the medical devices sector. This U.S.-based company is making significant strides in the treatment of diabetes with..
Evolus, Inc. (NASDAQ: EOLS), a healthcare company specializing in the aesthetic market, is capturing investor attention with a remarkable potential upside of 153%. Trading at $9.30, the company is navigating..
iRadimed Corporation (NASDAQ: IRMD) stands at the forefront of innovation in the healthcare sector, particularly within the medical devices industry. Based out of Winter Springs, Florida, this company has carved..
HealthStream, Inc. (NASDAQ: HSTM) stands as a notable player in the healthcare information services industry, offering innovative SaaS-based applications designed to enhance the operations of healthcare organizations across the United..
In the ever-evolving landscape of biotechnology, Nurix Therapeutics, Inc. (NASDAQ: NRIX) stands out as a compelling opportunity for investors seeking high growth potential. With a market capitalization of approximately $885.86..
Investors eyeing opportunities in the healthcare sector might find AMN Healthcare Services Inc (NYSE: AMN) an intriguing prospect, especially given its potential upside of 18.73%. As a leader in providing..
SI-BONE, Inc. (NASDAQ: SIBN), a prominent player in the healthcare sector, specifically within the medical devices industry, presents an intriguing investment opportunity for those interested in the innovative solutions targeting..
Investors in the biotechnology sector are continually on the lookout for companies with promising growth potential and innovative therapies. Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a commercial-stage biopharmaceutical company based..
In the dynamic landscape of healthcare investments, InMode Ltd. (NASDAQ: INMD) presents a compelling opportunity, particularly for those interested in the medical devices sector. With its headquarters in Yokne’am, Israel,..
Phibro Animal Health Corporation (NASDAQ: PAHC) operates within the competitive healthcare sector, focusing on the specialty and generic drug manufacturing industry. Headquartered in Teaneck, New Jersey, Phibro is a prominent..
Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology firm based in Waltham, Massachusetts, is captivating investor interest with its substantial potential upside of 197.15%. The company is at the forefront of developing..
For investors with a keen eye on the biotechnology sector, Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) presents an intriguing proposition. With a market capitalization of $833.8 million, this New York-based biopharmaceutical..
CureVac N.V. (NASDAQ: CVAC), the German biopharmaceutical company, is making waves in the biotechnology sector with its cutting-edge mRNA technology. Known for its innovative approach to developing transformative medicines, CureVac’s..
